| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.4B | $4.0B | $4.0B | $4.2B | $3.7B | $3.4B | $0.9B | $0.9B |
| Cost of Revenue | $0.6B | $0.6B | $0.6B | $0.6B | $0.5B | $0.4B | $0.5B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.0B | $0.9B | $0.9B | $0.9B | $0.8B | $0.7B | $0.2B | $0.1B |
| Net Income | $0.8B | $0.7B | $0.7B | $0.7B | $0.7B | $0.6B | $0.6B | $0.5B |
| EPS (Basic) | $3.15 | $2.69 | $2.78 | $2.73 | $2.63 | $2.47 | $2.34 | — |
| EPS (Diluted) | $3.14 | $2.69 | $2.78 | $2.73 | $2.63 | $2.47 | $0.46 | $0.36 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $25.0B | $22.7B | $21.2B | $20.2B | $18.6B | $17.7B | $16.7B | $15.4B |
| Current Assets | $1.7B | $1.2B | $1.3B | $1.3B | $1.1B | $0.9B | $0.9B | $0.8B |
| Cash & Equivalents | $0.6B | $0.1B | $0.1B | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $2.1B | $2.7B | $2.3B | $2.4B | $2.1B | $1.3B | $2.1B | $1.6B |
| Stockholders' Equity | $7.3B | $7.0B | $6.8B | $6.3B | $6.0B | $5.7B | $5.2B | $4.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $1.2B | $0.9B | $0.5B | $0.6B | $0.5B | $0.7B | $0.5B |
| Investing Cash Flow | $-1.9B | $-1.5B | $-1.4B | $-0.9B | $-0.7B | $-1.0B | $-1.3B | $-1.1B |
| Capital Expenditures | — | — | — | $1.5B | $1.2B | $1.4B | $1.6B | $1.6B |
| Financing Cash Flow | $1.2B | $0.4B | $0.6B | $0.4B | $0.1B | $0.5B | $0.6B | $0.5B |